Contatti:

cell: +39 329 0364389​

info@biomole.it

logo
logo

biomole@ALL RIGHT RESERVED 2019

cookie Policy | Privacy policy

201904151249411
schermata2021-01-15alle09.58.00

FLU SARS-CoV-2 

cod. BM-025

 

Principle of the test : Qualitative detection and differentiation of SARS-CoV-2 and Influenza A / Influenza B

Technology : One Step RT- PCR Real Time

Gene Target : N Nucleocapsid

Gene Target : M1 matrix gene Influenza A and NS2 nonstructural 2 gene Influenza B

Internal Control: GAPDH

Specimen : Respiratory specimens

Results : positive / negative

Number of tests : 50 tests BM-025 or kit 200 tests BM-025b

Kit storage : -20°C

Necessary equipment : 7500 Real Time PCR System or CFX96 Detection System

 

FLU SARS-CoV-2
 

The Influenza SARS-CoV-2 (Flu SARS-CoV-2) is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2 and influenza A virus / influenza B virus nucleic acid in respiratory specimens.

The Influenza SARS-CoV-2 (Flu SARS-CoV-2) is a multiplex assay, run in a single well/vessel, and is intended for use in the detection and differentiation of SARS-CoV-2 and influenza A/B viral RNA in patient specimens.

One Step Reverse Transcription Real Time polymerase chain reaction, the product contains oligonucleotide primers and dual-labeled
hydrolysis probes and control material used in rRT-PCR for the in vitro qualitative detection and differentiation of SARS-CoV-2 virus RNA, influenza A/B virus RNA. The oligonucleotide primers and probe for detection of SARS-CoV-2 were selected from an evolutionarily conserved region of the 3’ terminus of SARS-CoV-2 genome and include part or the carboxy-terminal portion of the nucleocapsid (N) gene. Primers and probes for the detection of influenza A viruses were selected from an evolutionarily well conserved region of the matrix (M1) gene. The primers and probe selected for detection of influenza B viruses were selected from a conserved region of the nonstructural 2 gene (NS2).